Magnetic seizure therapy in treatment-resistant depression: Clinical, neuropsychological and metabolic effects

Psychological Medicine

Volumn 45, Issue 5, 2015, Pages 1073-1092

  Kayser, S ^a   Bewernick, B H ^a   Matusch, A ^b   Hurlemann, R ^a   Soehle, M ^a   Schlaepfer, T E ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cognition; efficacy; magnetic seizure therapy; major depression; positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ANXIETY; BRAIN; CONTROLLED STUDY; CONVULSIVE THERAPY; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; FRONTAL LOBE; HUMAN; MAGNETOTHERAPY; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCINTISCANNING; TREATMENT OUTCOME;

ADULT; ANXIETY; BRAIN; CONVULSIVE THERAPY; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; HUMANS; MAGNETIC FIELD THERAPY; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; QUALITY OF LIFE; RADIOPHARMACEUTICALS; RECURRENCE; TREATMENT OUTCOME;

EID: 84924674456     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291714002244     Document Type: Article

References (101)

1. th edn. American Psychiatric Association: Washington, DC.
2. APA (2000). Handbook of Psychiatric Measures. American Psychiatric Association: Washington, DC.
3. APA (2001). The Practice of ECT: Recommendations for Treatment, Training and Privileging. American Psychiatric Association: Washington, DC.
4. Aschenbrenner A, Tucha O, Lange K (eds) (2000). RWT Regensburger Wortflüssigkeits-Test. Handanweisung. Hogrefe: Göttingen.
5. Austin MP, Mitchell P, Goodwin GM (2001). Cognitive deficits in depression: possible implications for functional neuropathology. British Journal of Psychiatry 178, 200-206.
6. Awata S, Konno M, Kawashima R, Suzuki K, Sato T, Matsuoka H, Fukuda H, Sato M (2002). Changes in regional cerebral blood flow abnormalities in late-life depression following response to electroconvulsive therapy. Psychiatry and Clinical Neurosciences 56, 31-40.
7. Azuma H, Fujita A, Otsuki K, Nakano Y, Kamao T, Nakamura C, Fujioi J, Otake H, Nishigaki M, Suzuki M, Kataoka M, Matsuzawa T, Sonoda M, Nakaaki S, Murata Y, Akechi T, Furukawa TA (2007a). Ictal electroencephalographic correlates of posttreatment neuropsychological changes in electroconvulsive therapy: a hypothesis-generation study. Journal of ECT 23, 163-168.
8. Azuma H, Fujita A, Sato K, Arahata K, Otsuki K, Hori M, Mochida Y, Uchida M, Yamada T, Akechi T, Furukawa TA (2007b). Postictal suppression correlates with therapeutic efficacy for depression in bilateral sine and pulse wave electroconvulsive therapy. Psychiatry and Clinical Neurosciences 61, 168-173.
9. Baddeley AD (1990). Human Memory: Theory and Practice. Lawrence Erlbaum Associates: London.
10. Baeumler G (ed.) (1985). Farbe-Wort-Interferenztest (FWIT) nach J.R. Stroop. Hogrefe: Göttingen.
11. Bartenstein P, Asenbaum S, Catafau A, Halldin C, Pilowski L, Pupi A, Tatsch K; European Association of Nuclear Medicine (2002). European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG. European Journal of Nuclear Medicine and Molecular Imaging 29, 43-48.
12. Beck A (ed.) (1987). Beck Depression Inventory: Manual. Psychological Corporation: San Antonio, TX.
13. Benedict RH, Zgaljardic DJ (1998). Practice effects during repeated administrations of memory tests with and without alternate forms. Journal of Clinical and Experimental Neuropsychology 20, 339-352.
14. Bernstein HJ, Beale MD, Berns C, Kellner CH (1998). Patients attitude about ECT after treatment. Annals of General Psychiatry 28, 524-527.
15. Bernstein JH, Waber DP (1996). Developmental Scoring System for the Rey-Osterrieth Complex Figure: Professional Manual. Psychological Assessment Resources: Odessa, FL.
16. Bertolote JM, Fleischmann A, De Leo D, Wasserman D (2004). Psychiatric diagnoses and suicide: revisiting the evidence. Crisis 25, 147-155.
17. Brickenkamp R (ed.) (1962). d2. Aufmerksamkeits-Belastungs-Test. Hogrefe: Göttingen.
18. Buschke H (1973). Selective reminding for analysis of memory and learning. Journal of Verbal Learning and Verbal Behavior 12, 543-550.
19. Cockrell JR, Folstein MF (1988).Mini-Mental State Examination (MMSE). Psychopharmacology Bulletin 24, 689-692.
20. Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates: Hillsdale, NJ.
21. Des Jarlais DC, Lyles C, Crepaz N (2004). Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. American Journal of Public Health 94, 361-366.
22. Devanand DP, Fitzsimons L, Prudic J, Sackeim HA (1995). Subjective side effects during electroconvulsive therapy. Convulsive Therapy 11, 232-240.
23. Dikmen SS, Heaton RK, Grant I, Temkin NR (1999). Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery. Journal of the International Neuropsychological Society 5, 346-356.
24. Drevets WC (2001). Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology 11, 240-249.
25. Fava GA, Ruini C, Mangelli L (2001). Patients with depression can be taught how to improve recovery. British Medical Journal 322, 1428.
26. Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papadopoulos A, Cleare AJ (2009). What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. Journal of Affective Disorders 116, 4-11.
27. Fink M (2001). Convulsive therapy: a review of the first 55 years. Journal of Affective Disorders 63, 1-15.
28. Fitzgerald PB, Hoy KE, Herring SE, Clinton AM, Downey G, Daskalakis ZJ (2013). Pilot study of the clinical and cognitive effects of high-frequency magnetic seizure therapy in major depressive disorder. Depression and Anxiety 30, 129-136.
29. Franke G (1995). SCL-90-R. The Symptom Checklist of Derogatis Revised. German Version [in German]. Beltz: Göttingen.
30. Fraser LM, O'Carroll RE, Ebmeier KP (2008). The effect of electroconvulsive therapy on autobiographical memory: a systematic review. Journal of ECT 24, 10-17.
31. Grunhaus L, Hirschman S, Dolberg OT, Schreiber S, Dannon PN (2001). Coadministration of melatonin and fluoxetine does not improve the 3-month outcome following ECT. Journal of ECT 17, 124-128.
32. Guze BH, Baxter Jr. LR, Schwartz JM, Szuba MP, Liston EH (1991). Electroconvulsive therapy and brain glucose metabolism. Convulsive Therapy 7, 15-19.
33. Haerting C, Markowitsch HJ, Neufeld H, Calabrese P, Deisinger K, Kessler J (eds) (2000). WMS-R. Wechsler Memory Scale - Revised [German adaptation]. Huber: Bern. Hamilton M (1967). Development of a rating scale for primary depressive illness. British Journal of Social Psychology 6, 278-296.
34. Hamilton M (ed.) (1976). HAMA. Hamilton Anxiety Scale. National Institute of Mental Health: Rockville, MD.
35. Helmstaedter C, Lendt M, Lux S (eds) (2001). VLMT. Verbaler Lern- und Merkfähigkeitstest . Beltz: Göttingen.
36. Holm S (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 6, 65-70.
37. Hooper HE (ed.) (1958). The Hooper Visual Organization Test. Western Psychological Services: Beverly Hills, CA.
38. Hoy KE, Thomson RH, Cherk M, Yap KS, Daskalakis ZJ, Fitzgerald PB (2013). Effect of magnetic seizure therapy on regional brain glucose metabolism in major depression. Journal of Psychiatric Research 211, 169-175.
39. Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T, Biggs MM, O'Connor K, Rasmussen K, Litle M, Zhao W, Bernstein HJ, Smith G, Mueller M, McClintock SM, Bailine SH, Kellner CH (2004). Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. Journal of Clinical Psychiatry 65, 485-491.
40. Jones SH, Thornicroft G, Coffey M, Dunn G (1995). A brief mental health outcome scale: reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry 166, 654-659.
41. Kayser S, Bewernick B, Axmacher N, Schlaepfer TE (2009). Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder. Journal of ECT 25, 137-140.
42. Kayser S, Bewernick BH, Grubert C, Hadrysiewicz BL, Axmacher N, Schlaepfer TE (2011). Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. Journal of Psychiatric Research 45, 569-576.
43. Kimball JN, Rosenquist PB, Dunn A, McCall V (2009). Prediction of antidepressant response in both 2.25 x threshold RUL and fixed high dose RUL ECT. Journal of Affective Disorders 112, 85-91.
44. Kirov G, Ebmeier KP, Scott AI, Atkins M, Khalid N, Carrick L, Stanfield A, O'Carroll RE, Husain MM, Lisanby SH (2008). Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. British Journal of Psychiatry 193, 152-155.
45. Kirwan CB, Bayley PJ, Galvan VV, Squire LR (2008). Detailed recollection of remote autobiographical memory after damage to the medial temporal lobe. Proceedings of the National Academy of Sciences USA 105, 2676-2680.
46. Kosel M, Frick C, Lisanby SH, Fisch HU, Schlaepfer TE (2003). Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology 28, 2045-2048.
47. Krystal AD, Weiner RD, Coffey CE, Smith P, Arias R, Moffett E (1992). EEG evidence of more 'intense' seizure activity with bilateral ECT. Biological Psychiatry 31, 617-621.
48. Krystal AD, Weiner RD, McCall WV, Shelp FE, Arias R, Smith P (1993). The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: an intraindividual crossover study. Biological Psychiatry 34, 759-767.
49. Krystal AD, West M, Prado R, Greenside H, Zoldi S, Weiner RD (2000). EEG effects of ECT: implications for rTMS. Depression and Anxiety 12, 157-165.
50. Laupacis A, Sackett DL, Roberts RS (1988). An assessment of clinically useful measures of the consequences of treatment. New England Journal of Medicine 318, 1728-1733.
51. Lehrl S (2005). MWT-B. Mehrfachwahl-Wortschatz-Intelligenztest. Spitta Verlag: Balingen.
52. Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A, Gilmer W, Marangell LB, Aaronson S, Daskalakis ZJ, Canterbury R, Richelson E, Sackeim HA, George MS (2009). Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 34, 522-534.
53. Lisanby SH, Luber B, Schlaepfer TE, Sackeim HA (2003). Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 28, 1852-1865.
54. Lisanby SH, Maddox JH, Prudic J, Devanand DP, Sackeim HA (2000). The effects of electroconvulsive therapy on memory of autobiographical and public events. Archives of General Psychiatry 57, 581-590.
55. Lisanby SH, Schlaepfer TE, Fisch HU, Sackeim HA (2001). Magnetic seizure therapy of major depression. Archives of General Psychiatry 58, 303-305.
56. Mayberg HS (2003). Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 65, 193-207.
57. McCaffrey RJ, Duff K, Westervelt HJ (2000). Practitioner's Guide to Evaluating Change with Intellectual Assessment Instruments. Kluwer Academic/Plenum Press: New York.
58. McCall WV, Robinette GD, Hardesty D (1996). Relationship of seizure morphology to the convulsive threshold. Convulsive Therapy 12, 147-151.
59. McNeely HE, Mayberg HS, Lozano AM, Kennedy SH (2008). Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. Journal of Nervous and Mental Disease 196, 405-410.
60. Mendlowicz MV, Stein MB (2000). Quality of life in individuals with anxiety disorders. American Journal of Psychiatry 157, 669-682.
61. Montgomery Jr. EB, Gale JT (2008). Mechanisms of action of deep brain stimulation (DBS). Neuroscience and Biobehavioral Reviews 32, 388-407.
62. Montgomery SA, Åsberg M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382-389.
63. Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA, Mann JJ (2001). Decreased regional brain metabolism after ECT. American Journal of Psychiatry 158, 305-308.
64. Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J (1993). EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biological Psychiatry 34, 321-330.
65. Ottosson JO, Max Fink M (eds) (2004). Ethics in Electroconvulsive Therapy. Brunner-Routledge: New York.
66. Parsons TD, Tucker KA, Hall CD, Robertson WT, Eron JJ, Fried MW, Robertson KR (2006). Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. Acquired Immune Deficiency Syndrome 20, 1591-1595.
67. Paykel ES (2008). Partial remission, residual symptoms, and relapse in depression. Dialogues in Clinical Neuroscience 10, 431-437.
68. Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, Rummans TA, O'Connor KM, Rasmussen Jr. KG, Bernstein HJ, Biggs M, Bailine SH, Kellner CH (2001). ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. Journal of ECT 17, 244-253.
69. Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA (2004). Effectiveness of electroconvulsive therapy in community settings. Biological Psychiatry 55, 301-312.
70. Regard M, Strauss E, Knapp P (eds) (1982). Der Fuenf-Punkt Test. Department of Neurology, University Hospital: Zurich.
71. Reitan RM (ed.) (1959). Trail Making Test. Indiana University Medical Center: Indianapolis, IN.
72. Ressler KJ, Mayberg HS (2007). Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nature Neuroscience 10, 1116-1124.
73. Rey A (ed.) (1964). L'Examen Clinique en Psychologie. Presse Universitaire de France: Paris.
74. Rose D, Fleischmann P, Wykes T, Leese M, Bindman J (2003). Patients' perspectives on electroconvulsive therapy: systematic review. British Medical Journal 326, 1363.
75. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M (2006). Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine 354, 1231-1242.
76. Rush AJ, Weissenburger J, Vinson DB, Giles DE (1983). Neuropsychological dysfunctions in unipolar nonpsychotic major depressions. Journal of Affective Disorders 5, 281-287.
77. Sackeim HA (1999). The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. Journal of ECT 15, 5-26.
78. Sackeim HA (2000). Memory and ECT: from polarization to reconciliation. Journal of ECT 16, 87-96.
79. Sackeim HA, George MS (2008). Brain stimulation - basic, translational and clinical research in neuromodulation: why a new journal? Brain Stimulation 1, 4-6.
80. Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J (2001). Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. Journal of the American Medical Association 285, 1299-1307.
81. Sackeim HA, Luber B, Moeller JR, Prudic J, Devanand DP, Nobler MS (2000a). Electrophysiological correlates of the adverse cognitive effects of electroconvulsive therapy. Journal of ECT 16, 110-120.
82. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM (1993). Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New England Journal of Medicine 328, 839-846.
83. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J (2000b). A prospective, randomized,double-blindcomparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Archives of General Psychiatry 57, 425-434.
84. Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M (2007). The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 32, 244-254.
85. Schatzberg AF, Kraemer HC (2000). Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biological Psychiatry 47, 736-744.
86. Schlaepfer TE, Agren H, Monteleone P, Gasto C, Pitchot W, Rouillon F, Nutt DJ, Kasper S (2012). The hidden third: improving outcome in treatment-resistant depression. Journal of Psychopharmacology 26, 587-602.
87. Semkovska M, McLoughlin DM (2010). Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biological Psychiatry 68, 568-577.
88. Silfverskiold P, Gustafson L, Risberg J, Rosen I (1986). Acute and late effects of electroconvulsive therapy.Clinical outcome, regional cerebral blood flow, and electroencephalogram. Annals of the New York Academy of Sciences 462, 236-248.
89. Spellman T, McClintock SM, Terrace H, Luber B, Husain MM, Lisanby SH (2008). Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biological Psychiatry 63, 1163-1170.
90. Takano H, Motohashi N, Uema T, Ogawa K, Ohnishi T, Nishikawa M, Kashima H, Matsuda H (2007). Changes in regional cerebral blood flowduring acute electroconvulsive therapy in patients with depression: positron emission tomographic study. British Journal of Psychiatry 190, 63-68.
91. Tewes U (ed.) (1991). HAWIE-R. Hamburg-Wechsler Intelligenztest fuer Erwachsene. Huber: Bern.
92. Thase ME, Rush AJ (1997). When at first you don't succeed: sequential strategies for antidepressant nonresponders. Journal of Clinical Psychiatry 58 (Suppl. 13), 23-29.
93. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR∗D: implications for clinical practice. American Journal of Psychiatry 163, 28-40.
94. UK ECT Review Group (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361, 799-808.
95. Warden D, Rush AJ, Wisniewski SR, Lesser IM, Kornstein SG, Balasubramani GK, Thase ME, Preskorn SH, Nierenberg AA, Young EA, Shores-Wilson K, Trivedi MH (2009). What predicts attrition in second step medication treatments for depression? A STAR∗D report. International Journal of Neuropsychopharmacology 12, 459-473.
96. Warden D, Trivedi MH, Wisniewski SR, Davis L, Nierenberg AA, Gaynes BN, Zisook S, Hollon SD, Balasubramani GK, Howland R, Fava M, Stewart JW, Rush AJ (2007). Predictors of attrition during initial (citalopram) treatment for depression: a STAR∗D report. American Journal of Psychiatry 164, 1189-1197.
97. Ware Jr. JE, Sherbourne CD (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 30, 473-483.
98. Weiner RD, Krystal AD (eds) (1993a). EEG Monitoring and Management of Electrically Induced Seizures. American Psychiatric Press: Washington, DC.
99. Weiner RD, Krystal AD (eds) (1993b). EEG Monitoring of ECT Seizures. American Psychiatric Press: Washington, DC.
100. White PF, Amos Q, Zhang Y, Stool L, Husain MM, Thornton L, Downing M, McClintock S, Lisanby SH (2006). Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesthesia and Analgesia 103, 76-80.
101. Wilson BA, Watson PC, Baddeley AD, Emslie H, Evans JJ (2000). Improvement or simply practice? The effects of twenty repeated assessments on peoplewith andwithout brain injury. Journal of the International Neuropsychological Society 6, 469-479.